Riskpilot← Back to searchSign inGet full accessAros läkarakademin AB
ABActiveOrg 5592681927Portalgatan 17 Lgh 1302General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
SEK 1,1M
-29% vs 2023
EBITDA margin
57.7%
-51% vs 2023
Equity ratio
66.6%
Financial strength
Net profit 2024
SEK 478K
-53% vs 2023
| Revenue | SEK 1,1M | -29% |
| EBITDA | SEK 658K | -51% |
| Net profit | SEK 478K | -53% |
| Total assets | SEK 3,7M | -2% |
| Equity | SEK 2,5M | +13% |
| Employees | 0 | — |
Legal name
Aros läkarakademin AB
Org number
5592681927
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
25 augusti 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet, medicinska undersökningar- och utredningar samt utbildning och fortbildning inom hälsa och sjukvård. Bolaget ska även tillhandahålla skönhetsvård och annan estetisk och kosmetisk kroppsvård. Utöver det skall bolaget även bedriva handel med aktier, värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Portalgatan 17 Lgh 1302
Email
bashir.atmari@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 711 | 1 401 | 1 606 | 1 141 |
| Staff expenses | — | — | −64 | −187 |
| EBITDA | 659 | 1 259 | 1 330 | 658 |
| Depreciation & amort. | −0 | −0 | — | — |
| EBIT | 659 | 1 259 | 1 330 | 658 |
| Net financials | — | — | −42 | −55 |
| Profit before tax | 659 | 1 258 | 1 288 | 603 |
| Tax | −141 | −259 | −265 | −126 |
| Net profit | 518 | 999 | 1 023 | 478 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 727 | 1 804 | 3 768 | 3 688 |
| Equity | 543 | 1 355 | 2 182 | 2 456 |
| Long-term debt | 0 | 0 | 990 | 970 |
| Short-term debt | 184 | 449 | 596 | 263 |
| Total debt | 184 | 449 | 1 586 | 1 233 |
EBITDA margin
57.7%
This company
15.8%
Market median
+265% vs market
20212024
Equity ratio
66.6%
This company
38.2%
Market median
+74% vs market
20212024
Return on equity
19.4%
This company
18.4%
Market median
+5% vs market
20212024
Net profit margin
41.8%
This company
8.1%
Market median
+416% vs market
20212024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20212024
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aros läkarakademin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bashir Atmari | Chief Executive Officer | 0 companies |
| Tukhfa Atmari | Deputy Board Member | 0 companies |